Organ failure, infection, and the systemic inflammatory response syndrome are associated with elevated levels of urinary intestinal fatty acid binding protein: Study of 100 consecutive patients in a surgical intensive care unit

Journal of Trauma - Injury, Infection and Critical Care

Volumn 45, Issue 5, 1998, Pages 900-906

  Lieberman, Joshua M ^a   Marks, William H ^a   Cohn, Stephen ^b   Jaicks, Russell ^c   Woode, Lawrence ^c   Sacchettini, James ^d   Fischer, Brian ^c   Moller, Beth ^c   Burns, Gerard ^c  

^a SWEDISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Swedish Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN;

ADOLESCENT; ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; FEMALE; HUMAN; INFECTION; INFLAMMATION; INTENSIVE CARE UNIT; INTESTINE ISCHEMIA; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

EID: 0031728552     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199811000-00011     Document Type: Conference Paper

References (37)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
2. Pinsky M. Organ-specific therapy in critical illness: interfacing molecular mechanisms with physiological interventions. J Crit Care. 1996;11:95-107.
3. Buchman T. Multiple organ failure. Curr Opin Gen Surg. 1993;26-31.
4. Nieuwenhuijzen G, Deitch E, Goris R. Infection, the gut and the development of the multiple organ dysfunction syndrome. Eur J Surg. 1996;162:259-273.
5. Aranow J, Fink M. Determinants of intestinal barrier failure in critical illness. Br J Anaesth. 1996;77:71-81.
6. Regel G, Grotz M, Weltner T. Pattern of organ failure following severe trauma. World J Surg. 1996;20:422-429.
7. 2 difference is a better marker of ischemia than intramural pH (pHi) or arterial pH-pHi difference. J Crit Care. 1996; 11:51-56.
8. Takala J. Determinants of splanchnic blood flow. Br J Anaesth. 1996;77:50-58.
9. Kuo P, Marks W, Lieberman J. et al. Systemic inflammatory response syndrome after human syngeneic intestinal transplant: evidence for disruption of enterocyte barrier function. Transplant Proc. 1996;28:2763-2764.
10. Wang X, Andersson R. The role of endothelial cells in the systemic inflammatory response syndrome and multiple system organ failure. Eur J Surg. 1995;161:703-713.
11. Matuschak G. Lung-liver interactions in sepsis and multiple organ failure syndrome. Clin Chest Med. 1996;17:83-98.
12. Ockner R, Manning J. Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport. J Clin Invest. 1974;54:326-338.
13. Veerkamp J, Paulussen R, Peeters R, et al. Detectoin, tissue distribution and (sub)cellular localization of fatty acid-binding protein types. Mol Cell Biochem. 1990;98:11-18.
14. Lieberman J, Sacchettinni J, Marks W, et al. Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery. 1997;121:335-342.
15. Kuo P, Morris J, Marks W, et al. Human syngeneic intestinal transplantation: evaluation of enterocyte viability with serum levels of intestinal fatty acid binding protein. Clin Transpl. 1996;10:282-286.
16. Kanda T, Fujii H, Fujita M, et al. Intestinal fatty acid binding protein is available for diagnosis of intestinal ischaemia: immunochemical analysis of two patients with ischaemic intestinal diseases. Gut. 1995;36:788-791.
17. Gollin G, Marks C, Marks W. Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery. 1993;113:545-551.
18. Marks W, Gollin G. Biochemical detection of small intestinal allograft rejection by elevated circulating levels of serum intestinal fatty acid binding protein. Surgery. 1993; 114:206-210.
19. Kanda T, Nakatomi Y, Ishikawa H. Intestinal fatty acid-binding protein as a sensitive marker of intestinal ischemia. Dig Dis Sci. 1992;37:1362-1367.
20. Kellum J, Decker J. The immune system: relation to sepsis and multiple organ failure. AACN Clinical Issues. 1996; 7:339-350.
21. Thijs L. Time course of cytokine levels in sepsis. Intensive Care Med. 1995;21:S258-S263.
22. Taylor D, Piantadosi C. Oxidative metabolism in sepsis and sepsis syndrome. J Crit Care. 1995;10:122-135.
23. Sauaia A, Moore F, Moore E, et al. Early risk factors for postinjury multiple organ failure. World J Surg. 1995; 20:392-400.
24. Galley H, Webster N. The immuno-inflammatory cascade. Br J Anaesth. 1996;77:11-16.
25. Godin P, Buchman T. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crut Care Med. 1996; 24:1107-1116.
26. Fujishima S, Aikawa N. Neutrophil-mediated tissue injury and its modulation. Intensive Care Med. 1995;21:277-285.
27. Gullo A, Berlot G. Ingredients of organ dysfunction or failure. World J Surg. 1996;20:430-436.
28. Carrico C, Meakins J, Marshall J. Multiple-organ-failure syndrome. Arch Surg. 1986;121:197-201.
29. Swank G, Deitch E. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg. 1996;720:411-417.
30. Schlag G, Redl H. Mediators of injury and inflammation. World J Surg. 1996;20:406-410.
31. Ivatury R, Simon R, Islam S, et al. A prospective randomized study of end points of resuscitation after major trauma: global oxygen transport indices versus organ-specific gastric mucosal pH. J Am Coll Surg. 1996;183:145-154.
32. Adan D, La Gamma E, Browne L. Nutritional management and the multisystem organ failure/systemic inflammatory response syndrome in critically ill preterm neonates. Crit Care Clin. 1995;11:751-783.
33. Ockner R, Manning J, Poppenhausen R, et al. A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues. Science. 1972;177:56-58.
34. Gordon J, Lowe J. Analyzing the structures, functions and evolution of two abundant gastrointestinal fatty acid binding proteins with recombinant DNA and computational techniques. Chem Phys Lipids. 1985;38:137-158.
35. Kanda T, Fujii H, Tani T, et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology. 1996;110:339-343.
36. Gollin G, Marks W. Early detection of small intestinal ischemia by elevated circulating intestinal fatty acid binding protein (I-FABP). Surg Forum. 1991;42:118-20.
37. Gollin G, Marks W. Elevation of circulating intestinal fatty acid binding protein in a luminal contents-initiated model of NEC. J Pediatr Surg. 1993;28:367-371.